Active substance
Results for the substance etrasimod
1 result
About this active substance
Etrasimod is a new medication used in the treatment of inflammatory bowel diseases such as ulcerative colitis. It works by modulating the immune system, reducing inflammation in the intestinal mucosa, and relieving symptoms such as diarrhea, abdominal pain, and rectal bleeding.
Etrasimod is usually administered as tablets, once daily, according to the gastroenterologist's instructions. The dose may be adjusted depending on the patient's response to treatment and any side effects.
Adverse effects may include headaches, nausea, respiratory infections, or increased liver enzyme levels. In rare cases, severe reactions may occur, which is why medical monitoring is necessary during treatment.
Etrasimod is a modern option for patients with inflammatory bowel diseases, offering the chance for better symptom control and improved quality of life.
Etrasimod is usually administered as tablets, once daily, according to the gastroenterologist's instructions. The dose may be adjusted depending on the patient's response to treatment and any side effects.
Adverse effects may include headaches, nausea, respiratory infections, or increased liver enzyme levels. In rare cases, severe reactions may occur, which is why medical monitoring is necessary during treatment.
Etrasimod is a modern option for patients with inflammatory bowel diseases, offering the chance for better symptom control and improved quality of life.